These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15946916

  • 1. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
    Griga T, Wilkens C, Schmiegel W, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Klein W.
    Eur J Med Res; 2005 May 20; 10(5):183-6. PubMed ID: 15946916
    [Abstract] [Full Text] [Related]

  • 2. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B.
    Hepatogastroenterology; 2005 May 20; 52(63):808-11. PubMed ID: 15966209
    [Abstract] [Full Text] [Related]

  • 3. A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses.
    Griga T, Wilkens C, Wirkus N, Epplen J, Schmiegel W, Klein W.
    Hepatogastroenterology; 2007 May 20; 54(75):784-6. PubMed ID: 17591062
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.
    Török HP, Glas J, Tonenchi L, Mussack T, Folwaczny C.
    Clin Immunol; 2004 Jul 20; 112(1):85-91. PubMed ID: 15207785
    [Abstract] [Full Text] [Related]

  • 5. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
    Baumgart DC, Buning C, Geerdts L, Schmidt HH, Genschel J, Fiedler T, Gentz E, Molnar T, Nagy F, Lonovics J, Lochs H, Wiedenmann B, Nickel R, Witt H, Dignass A.
    Digestion; 2007 Jul 20; 76(3-4):196-202. PubMed ID: 18174680
    [Abstract] [Full Text] [Related]

  • 6. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A, Palmieri O, Valvano MR, D'Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):241-8. PubMed ID: 17944996
    [Abstract] [Full Text] [Related]

  • 7. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May 01; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 8. The CD14 -159C-to-T promoter polymorphism in periodontal disease.
    Folwaczny M, Glas J, Török HP, Fricke K, Folwaczny C.
    J Clin Periodontol; 2004 Nov 01; 31(11):991-5. PubMed ID: 15491315
    [Abstract] [Full Text] [Related]

  • 9. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
    Wang F, Tahara T, Arisawa T, Shibata T, Nakamura M, Fujita H, Iwata M, Kamiya Y, Nagasaka M, Takahama K, Watanabe M, Hirata I, Nakano H.
    J Gastroenterol Hepatol; 2007 Jun 01; 22(6):925-9. PubMed ID: 17565650
    [Abstract] [Full Text] [Related]

  • 10. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease.
    Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Runte M, Epplen JT.
    Electrophoresis; 2000 Nov 01; 21(17):3578-82. PubMed ID: 11271474
    [Abstract] [Full Text] [Related]

  • 11. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML, Kennedy M, Roberts R, Shelling AN, Philpott M, Han DY, Ferguson LR.
    Hum Immunol; 2009 Jun 01; 70(6):440-6. PubMed ID: 19275920
    [Abstract] [Full Text] [Related]

  • 12. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
    Bernardo E, Angiolillo DJ, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C, Fernandez-Ortiz A.
    Am J Cardiol; 2006 Nov 01; 98(9):1182-4. PubMed ID: 17056323
    [Abstract] [Full Text] [Related]

  • 13. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production.
    Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TM.
    Genes Immun; 2004 Aug 01; 5(5):426-30. PubMed ID: 15164100
    [Abstract] [Full Text] [Related]

  • 14. Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis.
    Shih HH, Lin TM, Chuang JH, Eng HL, Juo SH, Huang FC, Chen CL, Chen HL.
    Pediatrics; 2005 Aug 01; 116(2):437-41. PubMed ID: 16061600
    [Abstract] [Full Text] [Related]

  • 15. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
    Pierik M, Vermeire S, Steen KV, Joossens S, Claessens G, Vlietinck R, Rutgeerts P.
    Aliment Pharmacol Ther; 2004 Aug 01; 20(3):303-10. PubMed ID: 15274667
    [Abstract] [Full Text] [Related]

  • 16. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection.
    Eng HL, Chen CH, Kuo CC, Wu JS, Wang CH, Lin TM.
    J Infect Dis; 2003 Jul 01; 188(1):90-7. PubMed ID: 12825176
    [Abstract] [Full Text] [Related]

  • 17. The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease.
    Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Schmiegel W, Griga T.
    Dig Liver Dis; 2005 Mar 01; 37(3):159-61. PubMed ID: 15888279
    [Abstract] [Full Text] [Related]

  • 18. Polymorphism in the promoter region of the CD14 gene and susceptibility to Brucellosis.
    Haidari M, Hajilooi M, Rezazadeh M, Rafiei A, Alavi SA, Keramat F.
    Immunol Invest; 2006 Mar 01; 35(2):239-45. PubMed ID: 16698680
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.
    Tedde A, Laura Putignano A, Bagnoli S, Congregati C, Milla M, Sorbi S, Genuardi M, Papi L.
    Scand J Gastroenterol; 2008 Mar 01; 43(6):712-8. PubMed ID: 18569989
    [Abstract] [Full Text] [Related]

  • 20. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH, Heijmans R, Chowers Y, Bar-Meir S, Avidan B, Pena AS, Crusius JB.
    Int J Immunogenet; 2006 Apr 01; 33(2):81-5. PubMed ID: 16611251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.